{"id":"https://openalex.org/W2529983003","doi":"https://doi.org/10.1097/jcp.0000000000000592","title":"Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial","display_name":"Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial","alternate_titles":[],"publication_year":2016,"publication_date":"2016-10-12","ids":{"openalex":"https://openalex.org/W2529983003","doi":"https://doi.org/10.1097/jcp.0000000000000592","mag":"2529983003","pmid":"https://pubmed.ncbi.nlm.nih.gov/27811556"},"language":"en","primary_location":{"id":"doi:10.1097/jcp.0000000000000592","doi":"https://doi.org/10.1097/jcp.0000000000000592","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0000000000000592","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2529983003"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084664288","display_name":"Arash Mowla","orcid":"https://orcid.org/0000-0002-2283-2751","observed_orcids":["https://orcid.org/0000-0002-2283-2751"]},"institutions":[{"id":"https://openalex.org/I166459259","display_name":"Shiraz University","ror":"https://ror.org/028qtbk54","country_code":"IR","type":"education","lineage":["https://openalex.org/I166459259"]},{"id":"https://openalex.org/I194604659","display_name":"Shiraz University of Medical Sciences","ror":"https://ror.org/01n3s4692","country_code":"IR","type":"education","lineage":["https://openalex.org/I194604659"]}],"countries":["IR"],"is_corresponding":true,"raw_author_name":"Arash Mowla","raw_affiliation_strings":["From the Substance Abuse and Mental Health Research Center, Department of Psychiatry, Shiraz University of Medical Sciences, Shiraz, Iran","the Substance Abuse and Mental Health Research Center, Department of Psychiatry, Shiraz University of Medical Sciences, Shiraz, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Substance Abuse and Mental Health Research Center, Department of Psychiatry, Shiraz University of Medical Sciences, Shiraz, Iran","institution_ids":["https://openalex.org/I166459259","https://openalex.org/I194604659"]},{"raw_affiliation_string":"the Substance Abuse and Mental Health Research Center, Department of Psychiatry, Shiraz University of Medical Sciences, Shiraz, Iran","institution_ids":["https://openalex.org/I166459259","https://openalex.org/I194604659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001733319","display_name":"Sanaz Boostani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166459259","display_name":"Shiraz University","ror":"https://ror.org/028qtbk54","country_code":"IR","type":"education","lineage":["https://openalex.org/I166459259"]},{"id":"https://openalex.org/I194604659","display_name":"Shiraz University of Medical Sciences","ror":"https://ror.org/01n3s4692","country_code":"IR","type":"education","lineage":["https://openalex.org/I194604659"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Sanaz Boostani","raw_affiliation_strings":["the Substance Abuse and Mental Health Research Center, Department of Psychiatry, Shiraz University of Medical Sciences, Shiraz, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Substance Abuse and Mental Health Research Center, Department of Psychiatry, Shiraz University of Medical Sciences, Shiraz, Iran","institution_ids":["https://openalex.org/I166459259","https://openalex.org/I194604659"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029473556","display_name":"Seyed Ali Dastgheib","orcid":"https://orcid.org/0000-0003-1628-4469","observed_orcids":["https://orcid.org/0000-0003-1628-4469"]},"institutions":[{"id":"https://openalex.org/I166459259","display_name":"Shiraz University","ror":"https://ror.org/028qtbk54","country_code":"IR","type":"education","lineage":["https://openalex.org/I166459259"]},{"id":"https://openalex.org/I194604659","display_name":"Shiraz University of Medical Sciences","ror":"https://ror.org/01n3s4692","country_code":"IR","type":"education","lineage":["https://openalex.org/I194604659"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Seyed Ali Dastgheib","raw_affiliation_strings":["the Substance Abuse and Mental Health Research Center, Department of Psychiatry, Shiraz University of Medical Sciences, Shiraz, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Substance Abuse and Mental Health Research Center, Department of Psychiatry, Shiraz University of Medical Sciences, Shiraz, Iran","institution_ids":["https://openalex.org/I166459259","https://openalex.org/I194604659"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5084664288"],"corresponding_institution_ids":["https://openalex.org/I166459259","https://openalex.org/I194604659"],"apc_list":null,"apc_paid":null,"fwci":1.4633,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.8026432,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"36","issue":"6","first_page":"720","last_page":"723"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":0.9129999876022339},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9430000185966492},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.8230000138282776},{"id":"https://openalex.org/keywords/treatment-resistant-ocd","display_name":"treatment-resistant OCD","score":0.9390000104904175},{"id":"https://openalex.org/keywords/augmentation-therapy","display_name":"augmentation therapy","score":0.7350000143051147},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.8820000290870667},{"id":"https://openalex.org/keywords/citalopram","display_name":"citalopram","score":0.996999979019165},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/y-bocs","display_name":"Yale-Brown Obsessive Compulsive Scale","score":0.9649999737739563}],"concepts":[{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.8857672214508057},{"id":"https://openalex.org/C3017582312","wikidata":"https://www.wikidata.org/wiki/Q178190","display_name":"Obsessive compulsive","level":2,"score":0.662661075592041},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45685532689094543},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.41745585203170776},{"id":"https://openalex.org/C2910564767","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine Hydrochloride","level":4,"score":0.4150081276893616},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.40844035148620605},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.32708051800727844},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068736","descriptor_name":"Duloxetine Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068736","descriptor_name":"Duloxetine Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000068760","descriptor_name":"Serotonin and Noradrenaline Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068760","descriptor_name":"Serotonin and Noradrenaline Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/jcp.0000000000000592","doi":"https://doi.org/10.1097/jcp.0000000000000592","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0000000000000592","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:27811556","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27811556","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W119591640","https://openalex.org/W1867335213","https://openalex.org/W1964540177","https://openalex.org/W1997452831","https://openalex.org/W2006001020","https://openalex.org/W2019737847","https://openalex.org/W2021327328","https://openalex.org/W2030313712","https://openalex.org/W2043237125","https://openalex.org/W2044731038","https://openalex.org/W2044965071","https://openalex.org/W2053800688","https://openalex.org/W2080500794","https://openalex.org/W2089304863","https://openalex.org/W2098354008","https://openalex.org/W2118826874","https://openalex.org/W2121017483","https://openalex.org/W2123778879","https://openalex.org/W2123822033","https://openalex.org/W2142474258","https://openalex.org/W2143180400","https://openalex.org/W2163732337","https://openalex.org/W2253040643","https://openalex.org/W2320983364","https://openalex.org/W2407736134","https://openalex.org/W2408767701","https://openalex.org/W2461935708"],"related_works":["https://openalex.org/W2730733122","https://openalex.org/W2142474258","https://openalex.org/W1966161934","https://openalex.org/W1524156168","https://openalex.org/W1984255668","https://openalex.org/W4244844159","https://openalex.org/W2171064051","https://openalex.org/W2530694902","https://openalex.org/W4233751537","https://openalex.org/W2143180400"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,73,97],"aim":[2],"of":[3,11,16,48,95,100,112,124,131,183,202],"this":[4],"study":[5,146,239],"is":[6,240],"to":[7,41,43,63,194,214,234,249],"evaluate":[8],"the":[9,80,109,137,144,189,251],"efficacy":[10],"duloxetine":[12,65,101,127,174,213],"augmentation":[13,23],"in":[14,93,126,133,185,204,220,226],"treatment":[15,49],"resistant":[17,229],"obsessive-compulsive":[18],"disorder":[19],"(OCD).":[20],"METHODS:":[21],"This":[22],"trial":[24,211],"was":[25,79,86,102,114],"designed":[26],"as":[27,88,155,216,218],"an":[28],"8-week":[29,145],"randomized":[30],"controlled,":[31],"double-blind":[32,208,244],"study.":[33],"Forty-six":[34,121],"patients":[35,122,190,227],"experiencing":[36],"OCD":[37],"who":[38],"had":[39],"failed":[40],"respond":[42],"at":[44,152],"least":[45],"12":[46],"weeks":[47],"with":[50,157,191,228],"a":[51,180,199],"selective":[52],"serotonin":[53],"reuptake":[54],"inhibitor":[55],"(fluoxetine,":[56],"citalopram,":[57],"or":[58,66,90],"fluvoxamine)":[59],"were":[60],"randomly":[61],"allocated":[62],"receive":[64],"sertraline":[67,113,134,192,219],"plus":[68,175],"their":[69,176,195],"current":[70],"anti-OCD":[71],"treatment.":[72],"Yale-Brown":[74],"Obsessive":[75],"Compulsive":[76],"Scale":[77],"(Y-BOCS)":[78],"primary":[81],"outcome":[82],"measure.":[83],"Treatment":[84],"response":[85],"defined":[87],"25%":[89],"more":[91],"decrease":[92,182,201],"scores":[94],"Y-BOCS.":[96,205],"mean":[98,110,181,200],"dosage":[99,111],"44.4":[103],"mg/d":[104,116],"(range,":[105,117],"20-60":[106],"mg/d),":[107],"and":[108,129,188,223,242],"123.8":[115],"50-200":[118],"mg/d).":[119],"RESULTS:":[120],"(24":[123],"30":[125],"group":[128],"22":[130],"27":[132],"group)":[135],"completed":[136],"trial.":[138],"Both":[139],"groups":[140],"showed":[141,212],"improvement":[142],"during":[143],"period":[147],"(mean":[148],"Y-BOCS":[149,186],"total":[150],"score":[151],"week":[153],"8":[154],"compared":[156],"baseline:":[158],"P":[159,163],"<":[160,164],"0.001":[161],"&":[162],"0.001)":[165],"without":[166],"significant":[167],"difference":[168],"(P":[169],"=":[170],"0.861).":[171],"Those":[172],"receiving":[173],"initial":[177,196],"medications":[178],"experienced":[179,198],"33.0%":[184],"score,":[187],"added":[193],"medication":[197],"34.5%":[203],"DISCUSSION:":[206],"Our":[207],"controlled":[209],"clinical":[210],"be":[215,235],"effective":[217],"reducing":[221],"obsessive":[222],"compulsive":[224],"symptoms":[225],"OCD.":[230],"However,":[231],"it":[232],"needs":[233],"noted":[236],"that":[237],"our":[238],"preliminary,":[241],"larger":[243],"placebo-controlled":[245],"studies":[246],"are":[247],"necessary":[248],"confirm":[250],"results.":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2529983003","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-10-21T00:00:00"}
